G Protein News and Research

RSS

ADAM-12 gene can serve as treatment target for cancer, arthritis, cardiac hypertrophy

ADAM-12 is not only the name of a 1970's television police drama - it's also the gene that University of Missouri researchers believe could be an important element in the fight against cancer, arthritis, and cardiac hypertrophy, or thickening of the heart's walls.

9 Mar 2011

Study: Roundworm protein can suppress inflammation in patients with sepsis

Research by the University of Liverpool has found that systemic inflammation caused by sepsis can be suppressed by a protein which occurs naturally in a type of roundworm.

8 Mar 2011

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Compugen Ltd. announced today positive animal model results for CGEN-25068, a novel peptide predicted and selected in silico to block a specific protein-protein interaction known to play an important role in various immune-related disease conditions.

8 Mar 2011

New discovery in childhood respiratory disease

Researchers have identified a critical part of the process by which one of the world's most common and dangerous early childhood infections, respiratory syncytial virus, causes disease.

8 Mar 2011

PHS announces result of OSHPD data on malnutrition rates at all of state's hospitals

Prime Healthcare Services, California's leading healthcare provider and one of the nation's top for-profit healthcare systems, today announced the result of a detailed review of California's 2009 Office of Statewide Health Planning and Development Data on malnutrition rates at all of the state's hospitals.

8 Mar 2011

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

Working as part of a public program to screen compounds to find potential medicines and other biologically useful molecules, scientists from The Scripps Research Institute and Massachusetts Institute of Technology (MIT) have discovered an extremely potent class of potential anti-cancer and anti-neurodegenerative disorder compounds.

8 Mar 2011

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

If you can't stop the beta-amyloid protein plaques from forming in Alzheimer's disease patients, then maybe you can help the body rid itself of them instead. At least that's what scientists from New York were hoping for when they found a drug candidate to do just that.

8 Mar 2011

Klotho protein discovery can lead to new class of drugs for treatment of obesity

An important discovery in mice may make a big difference in people's waistlines thanks to a team of Harvard scientists who found that reducing the function of a transmembrane protein, called Klotho, in obese mice with high blood sugar levels produced lean mice with reduced blood sugar levels.

8 Mar 2011

UTHealth study: Children with H. pylori infection have lower levels of iron

Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.

8 Mar 2011

Two studies show how laminin plays a central role in breast cancer development

Laminin, long thought to be only a structural support protein in the microenvironment of breast and other epithelial tissues, is "famous" for its cross-like shape.

8 Mar 2011

New study reveals role of INK4, ARF proteins in Burkitt's lymphoma

Burkitt's lymphoma is one of the most aggressive tumors affecting humans. Multiple alterations in genes that regulate cell proliferation rate explain its aggressive behavior.

8 Mar 2011

New Lupus drug marching towards approval

A new drug for lupus from the Human Genome Sciences Inc is all set to get clearance in the US this week. If all goes through, this drug will offer patients the first approved treatment option in a half-century, setting the manufacturer up for huge sales.

7 Mar 2011

Duchenne Parent Project awards grant to AMT for DMD gene therapy

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the Duchenne Parent Project, based in the Netherlands, has awarded AMT a grant of EUR 145,000 to support the development of AMT-080, AMT's gene therapy for Duchenne Muscular Dystrophy.

7 Mar 2011

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

The 18th Conference on Retroviruses and Opportunistic Infections is being held at the Hynes Convention Center in Boston from February 27 through March 2. Day three of this major HIV/AIDS research conference included the following selected presentations from scientists supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Mar 2011

ADM, Burcon NutraScience enter license agreement to market CLARISOY soy protein

Burcon NutraScience Corporation announced today that the company has entered into a license agreement with Archer Daniels Midland Company for the worldwide production, distribution and sale of Burcon's CLARISOY soy protein.

5 Mar 2011

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center. They say the treatment - which is given just once - could potentially do the same in people at the beginning stages of the disease.

5 Mar 2011

Scientists detail role of TDP-43 in ALS pathology

Amyotrophic lateral sclerosis, known as ALS or more popularly, Lou Gehrig's disease, is a notorious neurodegenerative condition characterized by the progressive deterioration of brain and spinal cord neurons, resulting in the gradual but catastrophic loss of muscle control and ultimately, death.

5 Mar 2011

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.

5 Mar 2011

Study: BMP can improve dental implant success

Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.

5 Mar 2011

Scientist discovers new mechanism for regulation of gene expression

Dr. David Levin, Professor of Molecular & Cell Biology at Boston University Henry M. Goldman School of Dental Medicine and Professor of Microbiology at Boston University School of Medicine discovered recently a novel, evolutionarily conserved mechanism for the regulation of gene expression.

4 Mar 2011

G Protein News and Research

ADAM-12 gene can serve as treatment target for cancer, arthritis, cardiac hypertrophy

Study: Roundworm protein can suppress inflammation in patients with sepsis

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

New discovery in childhood respiratory disease

PHS announces result of OSHPD data on malnutrition rates at all of state's hospitals

Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

Klotho protein discovery can lead to new class of drugs for treatment of obesity

UTHealth study: Children with H. pylori infection have lower levels of iron

Two studies show how laminin plays a central role in breast cancer development

New study reveals role of INK4, ARF proteins in Burkitt's lymphoma

New Lupus drug marching towards approval

Duchenne Parent Project awards grant to AMT for DMD gene therapy

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

ADM, Burcon NutraScience enter license agreement to market CLARISOY soy protein

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Scientists detail role of TDP-43 in ALS pathology

Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study

Study: BMP can improve dental implant success

Scientist discovers new mechanism for regulation of gene expression

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News